MediPal Holdings Corporation (MAHLY)

Market Cap	4.11B +13.8%
Revenue (ttm)	23.76B +4.2%
Net Income	286.65M +14.0%
EPS	1.40 +15.7%
Shares Out	n/a
PE Ratio	14.34
Forward PE	n/a
Dividend	0.50 (2.64%)
Ex-Dividend Date	Sep 29, 2026

Volume	672
Open	18.76
Previous Close	18.76
Day's Range	18.76 - 18.76
52-Week Range	15.37 - 20.35
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About MediPal Holdings

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database. It is also involved in the wholesale of cosmetics, daily ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,024
• Stock Exchange: OTCMKTS
• Ticker Symbol: MAHLY

Financial Performance

In fiscal year 2026, MediPal Holdings's revenue was 3.82 trillion, an increase of 3.98% compared to the previous year's 3.67 trillion. Earnings were 42.53 billion, an increase of 5.60%.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 25, 2026

Data Sources Report a data error